SEMAX: Reported Benefits, Side Effects and the State of the Evidence
Also referenced as: ACTH (4-10) analogue
A literature-led overview of SEMAX — what has actually been measured in the published record, what remains unknown, and how research-grade material is characterised.
4 min read · Literature review · Updated 2026
Research-grade SEMAX vials — ≥99% HPLC purity, lot-matched COA on request, from $23.96.
Shop SEMAXWhat SEMAX is
A synthetic ACTH fragment analogue studied in neurochemistry and behavioural models.
Research material is supplied as a lyophilised powder in a sealed vial, reconstituted with bacteriostatic water immediately before use and characterised by reverse-phase HPLC with identity confirmed by mass spectrometry. The published record for SEMAX is dominated by preclinical sources, which is the most important caveat when reading any summary of its reported effects.
Reported benefits of SEMAX in the literature
The areas below summarise what published work has actually measured. Each is an observation reported in the cited literature — not a claimed outcome, and not a statement of efficacy in humans.
Cognitive / neuro research
Rodent models have investigated BDNF-associated expression endpoints.
How it is described mechanistically
Mechanistic descriptions of SEMAX in the literature centre on the pathways below. Pathway attributions should be read as proposed rather than settled.
Neurotrophin expression
Rodent studies report association with BDNF and TrkB expression changes. Pathway noted in the literature: BDNF/TrkB.
SEMAX side effects and safety data gaps
Published human data are limited and largely outside peer-reviewed English-language literature.
No consistent adverse-event profile has been established for SEMAX. The meaningful limitation is absence of data rather than a documented list of effects.
Open data gaps: randomised controlled human trials. Peptide Lounge does not publish dosing or administration guidance for any compound, and this material is not for human or veterinary use.
Purity, testing and handling for research use
Every SEMAX lot is released at ≥99% purity by RP-HPLC with identity confirmed by ESI-MS, and a lot-matched certificate of analysis is available on request rather than a generic sample document.
Vials ship lyophilised and sealed, and are stable at ambient temperature during transit. Store unreconstituted vials refrigerated and protected from light; once reconstituted, keep refrigerated and treat the solution as short-dated. Experimental concentrations must be determined by the researcher from the peer-reviewed literature under their own institutional protocol.
How researchers source SEMAX
SEMAX is stocked as a 10mg single-compound vial, with volume pricing applied automatically to multi-vial orders. Free bacteriostatic water and research supplies are included on qualifying orders.
Related research vials
SEMAX — frequently asked questions
What are the reported benefits of SEMAX?
Published work describes cognitive / neuro research. These findings come from preclinical or in-vitro studies rather than controlled human trials.
What side effects have been reported for SEMAX?
No established adverse-event profile exists. The substantive limitation is missing data: randomised controlled human trials.
Is SEMAX approved for human use?
No. SEMAX supplied by Peptide Lounge is a laboratory reagent for in-vitro and laboratory research only. It is not an approved drug and is not for human or veterinary use.
How is SEMAX stored and reconstituted?
Store lyophilised vials refrigerated and protected from light. Reconstitute with bacteriostatic water immediately before use and keep the resulting solution refrigerated. Vials remain stable at ambient temperature during shipping.
How do I verify the purity of a SEMAX vial?
Request the lot-matched certificate of analysis for the batch you received. It reports RP-HPLC purity (≥99%) and ESI-MS identity confirmation for that specific lot.
Research areas
Cognitive / neuro research
Preclinical dataRodent models have investigated BDNF-associated expression endpoints.
Mechanisms of action (as described in literature)
Neurotrophin expression
Preclinical dataRodent studies report association with BDNF and TrkB expression changes.
BDNF/TrkB
Published studies
No peer-reviewed study links are curated for this compound yet. Available information is limited to analytical and preclinical sources. Absence of linked studies should be read as an evidence gap.
Safety signals & data gaps
Reported signals only — safety is not established
Published human data are limited and largely outside peer-reviewed English-language literature.
Known data gaps: Randomised controlled human trials.
For Research Use Only
All products listed are supplied strictly as laboratory reagents for in-vitro research and analytical work conducted by qualified professionals. They are not drugs, foods, cosmetics or medical devices, and must not be administered to humans or animals. No product on this site is approved by the FDA for human use.
Research Use Only: Products are sold strictly for laboratory research and educational purposes only. Not for human consumption, veterinary use, food use, cosmetic use, or therapeutic application. Products are not intended to diagnose, treat, cure, or prevent any disease.